x

    Request a Callback

    Fill in your details and our team will get in touch with you.


    Newsletter

    • Featured
    • Newsletter

    1Cell ERA Newsletter | July 2026

    The July 2026 edition of the 1Cell.Ai Newsletter explores a pivotal moment in precision oncology, when emerging evidence becomes clinical practice. This issue unpacks the latest NCCN Bladder Cancer guideline update endorsing ctDNA-based minimal residual disease (MRD) testing for treatment...
    • 2 mins read
    • Featured
    • Newsletter

    1Cell ERA Newsletter | June 2026

    ASCO 2026 delivered a defining moment for precision oncology, and the 1Cell.Ai June 2026 Edition Newsletter captures why. From landmark trial data reshaping treatment sequencing to a deeper understanding of how tumours evolve resistance in real time, this month’s research...
    • 2 mins read
    • Featured
    • Newsletter

    1Cell ERA Newsletter | May 2026

    The fast-moving world of precision oncology demands an operational engine that is just as sophisticated as the science behind it. In the May 2026 edition of the 1Cell.Ai newsletter, CEO Mohan Uttarwar introduces a purposeful organizational transformation. Led by industry...
    • 2 mins read
    Loading...
    1Cell.Ai
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.